Company Search:
Advanced Search
Sponsored Links
Medinet Co., Ltd. Company Snapshot
Medinet Co., Ltd. operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other companies in this sector in Japan: Carna Biosciences Inc (2015 sales of 1.57 billion Japanese Yen [US$15.14 million] of which 61% was Drug Discovery Support Business), Symbio Pharmaceuticals Ltd (1.93 billion Japanese Yen [US$18.66 million] of which 100% was Auxiliary Business), and Tella Incorporation (1.91 billion Japanese Yen [US$18.43 million] of which 54% was Cell Therapy Technology Development Busi).

Sales Analysis. Medinet Co., Ltd. reported sales of ¥1.67 billion (US$16.16 million) for the fiscal year ending September of 2015. This represents a decrease of 9.2% versus 2014, when the company's sales were ¥1.84 billion. Contributing to the drop in overall sales was the 9.5% decline in Cell Processing, from ¥1.84 billion to ¥1.67 billion. . However, these declines were partially offset by the increase in sales of Cell Therapy Products Business (up 178.4% to ¥8.36 million) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medinet Co., Ltd.
  Stock Performance Chart for Medinet Co., Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): 145.00
(Figures in Japanese Yen)
1 Week -1.4%   13 Weeks -2.7%  
4 Weeks 8.2%   52 Weeks -13.7%  
Medinet Co., Ltd. Key Data:
  Ticker: 2370 Country: Japan
  Exchanges: TYO OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 1,674,379,000
(Year Ending Jan 2016).
Employees: 180
  Currency: Japanese Yen Market Cap: 13,438,311,305
  Fiscal Yr Ends: September Shares Outstanding: 92,678,009
  Share Type: Common Closely Held Shares: 12,761,642
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.